U.S. Specialized REITs Stock News

Velocity Financial stock barely flinched after earnings, edging up about 1.5% to close near US$18.50. For a lender with a P/E of 6.8x and a trailing net margin above 38%, that is a muted reaction to a quarter built around one thing that matters most: the spread the company earns on its loan book is quietly widening. Core net income reached US$27.9m and pre tax income came in at US$35.2m, while portfolio net interest margin held above the stated 3.5% target. The short term move looks modest...

Office Properties Income Trust walked into this earnings season with a battered reputation and a fresh start after Chapter 11. The stock has inched up about 1% today, hardly a verdict on a company that just cut roughly US$714m of debt and is still carrying about US$1.7b of borrowings at an average interest cost near 9%. The headline from this quarter is not earnings per share. It is cash. Normalized funds from operations of US$19m and adjusted EBITDAre of US$65m set the stage for the real...

ICU Medical entered this quarter with a stock that had already run hard, then the earnings drop pushed it even higher. The share price jumped 10.8% to about $184 in regular trading, a strong vote of confidence from investors who have been debating whether this medical equipment maker is simply cheap or fundamentally improving. The headline this time is profit quality. Adjusted earnings per share of $2.37 and adjusted EBITDA of $110 million, built on roughly $548 million of sales, point to...

Mueller Water Products stock slipped about 1.6% to US$26.67 into the close, even as the company reported its strongest profitability of the year. The headline is margin power. Adjusted EBITDA margin reached a record 27.1% on US$395.9 million of net sales, and basic earnings per share for the quarter came in at roughly US$0.43. Short term traders focused on the modest price move. Long term investors may be more interested in the implications of this margin profile and cash generation over the...

Chiron Real Estate stock barely budged after earnings, up about 1% to US$35.46. This suggests the market has not fully reacted to what just hit the tape. The headline is simple: core real estate cash generation looked solid while the story around reported profit stayed complicated. The key figure for a real estate investment trust is Funds From Operations, and Chiron Real Estate produced US$12.7m in the quarter with FFO per share of US$0.88. Reported net income from ongoing operations came in...

Caris Life Sciences stock jumped 13.7% to US$22.74 after earnings, and the emotional beat is clear. Investors focused on the headline that this is now a profitable cancer testing platform with rapid top line momentum, rather than a cash burn story. Q2 revenue reached US$263.7m and adjusted EBITDA was positive at US$55.7m, which matters in a sector where many peers still post heavy operating losses. The key question for investors is whether this surge simply caught up with the fundamental...

Walker & Dunlop stock barely budged after earnings, ticking up 0.4% to US$44.42, even though the quarterly headline was anything but calm. Reported earnings per share dropped to just US$0.09 as fresh charges from the legacy borrower fraud issue again hit the income statement. The market’s cool reaction sits against a much bigger tension for you as an investor. The company still carries a P/E of 40x and a 6.1% dividend yield that current earnings and cash flow struggle to cover. The next few...

Liquidity Services entered this earnings release with a quietly strong run, with the stock up around 16% over the past three months, and the market barely flinched today with a 0.1% move. That calm surface hides a punchy quarter. The company posted Q3 revenue of US$129.6m and basic earnings per share of US$0.33, while gross merchandise volume reached US$453m. Management also highlighted its 10th straight quarter of year over year adjusted EBITDA growth, which puts execution, not hype, at the...

Tariffs on imported polysilicon and new minimum prices on some solar imports have suddenly put a spotlight on U.S. solar energy stocks. With First Solar and Solaredge Technologies reacting quickly in premarket trading, investors are watching for potential winners from reduced Chinese competition and a possible lift to domestic manufacturing. This article walks through three U.S. solar related stocks exposed to this news and explains why their stories matter now. The stocks covered below are...

Monolithic Power Systems reported past second-quarter 2026 results with sales of US$980.64 million and net income of US$257.30 million, issued third-quarter revenue guidance of US$1.14–1.16 billion, and expanded its share buyback authorization to US$1.00 billion. The combination of strong earnings growth, upbeat revenue expectations, and a larger repurchase program highlights management’s confidence in the company’s cash generation and demand outlook. We’ll now examine how the stronger...

Xeris Biopharma walked into this earnings print with a stock that had slipped over the past month and week, yet the market snapped back fast. The share price jumped 7.6% today to US$7.92. That reaction is all about one thing. Investors saw a high growth specialty pharma story deliver record Q2 revenue of US$92.1m while absorbing a sizeable one time noncash GAAP hit tied to retiring its 2028 convertible notes. The headline is simple. Strong top line momentum collided with a cleaner capital...

Republic Services walked into this earnings day with a reputation as a steady compounder and a stock that had cooled slightly over the past month. The market did not wait for the clean up. Shares jumped about 2.4% to around US$214.51 as investors digested a quarter built on firm pricing power and a raised full year outlook. For a waste and environmental services stock, the headline is simple. Revenue of US$4.43b and adjusted earnings per share of about US$1.85 reinforced the story that...

BioMarin Pharmaceutical stock closed up 3.7% at US$63.75, which indicates the market responded positively to the news. The question is whether that move really reflects what just happened in the quarter. Revenue was approximately US$989.7m in Q2 while basic earnings per share came in at US$0.23, and management raised full year guidance for both sales and non generally accepted accounting principles earnings per share. In short, traders were willing to pay more for BioMarin Pharmaceutical...

Summit Hotel Properties came into this print looking like a recovery value story, with the stock up over the past three months but slipping 2.8% today to US$6.49 as investors digested the latest numbers. The headline is simple. Q2 flipped back into the black on a basic earnings per share basis and management backed that up with a higher full year outlook for adjusted funds from operations and revenue per available room. For a hotel real estate investment trust, that shift in profitability and...

ArcBest (ARCB) shares came into focus after the company reported second quarter 2026 results that combined higher sales with a swing to net loss, prompting investors to reassess profitability and capital return initiatives. See our latest analysis for ArcBest. At a share price of $137.76, ArcBest has seen its momentum cool slightly in the last month, with a 30 day share price return of a 5.56% decline, although the year to date share price return of 78.52% and 1 year total shareholder return...

Establishment Labs Holdings slipped 2.2% to US$77.33 after its Q2 report, a muted move for a stock that has already been soft over the past month. The headline is simple: revenue reached US$67.5m and the company turned adjusted EBITDA positive at US$3.7m while pushing gross margin to 70.6%. The near term story is still about losses and a premium valuation, with the stock trading on a trailing P/S of 9.3x versus much lower industry averages. The longer term question is whether the minimally...

Millicom International Cellular stock took a sharp hit, dropping about 7% today, even as the quarter delivered headline numbers many telecom investors usually want to see. Service revenue reached about US$2.0b and adjusted earnings before interest, tax, depreciation and amortisation climbed to a record US$1.0b, with a strong equity free cash flow print of US$327m. For a company often framed as a balance between growth and balance sheet risk, that selloff sets up a clear tension. The market...

The market just swung hard in Twilio’s favor, with the stock jumping almost 25% in a single session, and the core reason sits squarely in profitability. Q2 basic earnings per share moved to about US$7 on roughly US$1.5b of revenue, turning a company long treated as a growth story into a clear profit story. That kind of earnings power in a communications software stock can quickly reset investor expectations. Today’s surge looks like a sentiment reset driven less by hype and more by a sharp...

SM Energy barely budged in regular trading, inching up 0.6% to about US$28.87, which indicates the market is treating this earnings report as business as usual. The fundamentals tell a different story. Q2 2026 delivered roughly US$2.5b in revenue and a swing to strong profitability with basic earnings per share above US$4. The key highlight is margin performance. Net income excluding one offs hit just over US$1b, which puts the stock’s muted move at odds with the profit engine the company...

White Mountains Insurance Group stock barely flinched after earnings, ticking up about 0.5% to around US$2,152. For a company with a US$80.58 quarterly earnings per share print and an 83.9% combined ratio in its core insurance operations, that is a muted response. The focus for you is not today’s move; it is that these results land on top of a trailing 12 month earnings profile shaped by a very large one off gain and a P/E of 4.6x that keeps the long term valuation debate wide open. Is White...

DNOW stock jumped 7.3% today, yet the headline story is not a sudden growth re-rating. It is that a chronic loss maker just printed another loss, only smaller. Revenue for the quarter came in at US$1.31b while DNOW reported a net loss of US$21m. That is a clear improvement on the US$44m loss in the prior quarter. For a stock that screens as cheap on simple sales multiples and discounted cash flow math, this quarter is about one thing: the profit squeeze is easing, but the turnaround is still...

Mitek Systems went into earnings with a flat month behind it and a reputation as a solid but fully priced fraud and identity stock. The market did not wait for nuance. The shares jumped almost 10% to about US$18.49 after the fiscal Q3 release. The move rested on one clear headline: profitability and cash generation in this quarter were strong for a software infrastructure company. Adjusted EBITDA margin was near the high 30s and free cash flow reached US$25.3m. That combination led investors...

FIGS jumped 27% today, with the stock closing near US$14 after a strong earnings jolt that caught short term traders off guard. The scrubwear specialist did not just post another solid quarter. It put profit margins at the center of the story. Net revenue reached US$196.6m for the quarter while net income was US$28.4m, and management lifted full year guidance for both revenue growth and adjusted EBITDA margin. The market reacted to the headline surprise. Long term holders will focus on...

Prestige Consumer Healthcare stock barely flinched after earnings, up less than 1% to about $54.90, which suggests investors saw nothing to disrupt the long term thesis on this consumer health compounder. The headline is quieter than the quarter. Revenue came in at about $265.7m and adjusted earnings per share ticked higher to $0.98, while free cash flow hit a record $83.7m. The real story for you is not a big beat or miss. It is how Prestige Consumer Healthcare is using that cash firepower...